Literature DB >> 33416452

Elevated postischemic tissue injury and leukocyte-endothelial adhesive interactions in mice with global deficiency in caveolin-2: role of PAI-1.

Yajun Liu1, Meifang Wang1, Derek Wang1, William P Fay1,2, Ronald J Korthuis1,3, Grzegorz Sowa1.   

Abstract

Ischemia/reperfusion (I/R)-induced rapid inflammation involving activation of leukocyte-endothelial adhesive interactions and leukocyte infiltration into tissues is a major contributor to postischemic tissue injury. However, the molecular mediators involved in this pathological process are not fully known. We have previously reported that caveolin-2 (Cav-2), a protein component of plasma membrane caveolae, regulated leukocyte infiltration in mouse lung carcinoma tumors. The goal of the current study was to examine if Cav-2 plays a role in I/R injury and associated acute leukocyte-mediated inflammation. Using a mouse small intestinal I/R model, we demonstrated that I/R downregulates Cav-2 protein levels in the small bowel. Further study using Cav-2-deficient mice revealed aggravated postischemic tissue injury determined by scoring of villi length in H&E-stained tissue sections, which correlated with increased numbers of MPO-positive tissue-infiltrating leukocytes determined by IHC staining. Intravital microscopic analysis of upstream events relative to leukocyte transmigration and tissue infiltration revealed that leukocyte-endothelial cell adhesive interactions in postcapillary venules, namely leukocyte rolling and adhesion were also enhanced in Cav-2-deficient mice. Mechanistically, Cav-2 deficiency increased plasminogen activator inhibitor-1 (PAI-1) protein levels in the intestinal tissue and a pharmacological inhibition of PAI-1 had overall greater inhibitory effect on both aggravated I/R tissue injury and enhanced leukocyte-endothelial interactions in postcapillary venules in Cav-2-deficient mice. In conclusion, our data suggest that Cav-2 protein alleviates tissue injury in response to I/R by dampening PAI-1 protein levels and thereby reducing leukocyte-endothelial adhesive interactions.NEW & NOTEWORTHY The role of caveolin-2 in regulating ischemia/reperfusion (I/R) tissue injury and the mechanisms underlying its effects are unknown. This study uses caveolin-2-deficient mouse and small intestinal I/R injury models to examine the role of caveolin-2 in the leukocyte-dependent reperfusion injury. We demonstrate for the first time that caveolin-2 plays a protective role from the I/R-induced leukocyte-dependent reperfusion injury by reducing PAI-1 protein levels in intestinal tissue and leukocyte-endothelial adhesive interactions in postcapillary venules.

Entities:  

Keywords:  Cav-2; I/R injury; PAI-1; leukocyte-endothelial adhesive interactions; postcapillary venules

Mesh:

Substances:

Year:  2021        PMID: 33416452      PMCID: PMC8362680          DOI: 10.1152/ajpheart.00682.2020

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  82 in total

1.  Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation.

Authors:  W P Fay; A D Shapiro; J L Shih; R R Schleef; D Ginsburg
Journal:  N Engl J Med       Date:  1992-12-10       Impact factor: 91.245

2.  Caveolin-2 is a negative regulator of anti-proliferative function and signaling of transforming growth factor-β in endothelial cells.

Authors:  Leike Xie; Chi Vo-Ransdell; Britain Abel; Cara Willoughby; Sungchan Jang; Grzegorz Sowa
Journal:  Am J Physiol Cell Physiol       Date:  2011-08-10       Impact factor: 4.249

3.  Distribution of plasminogen activator inhibitor (PAI-1) in tissues.

Authors:  A J Simpson; N A Booth; N R Moore; B Bennett
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

Review 4.  The adipocyte and hemostatic balance in obesity: studies of PAI-1.

Authors:  D J Loskutoff; F Samad
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-01       Impact factor: 8.311

5.  Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal.

Authors:  C J Chiu; A H McArdle; R Brown; H J Scott; F N Gurd
Journal:  Arch Surg       Date:  1970-10

6.  Caveolin-2 in urine as a novel biomarker of renal recovery after cisplatin induced nephrotoxicity in rats.

Authors:  Romina P Bulacio; Adriana M Torres
Journal:  Toxicol Lett       Date:  2019-07-05       Impact factor: 4.372

7.  Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.

Authors:  Alec D Weisberg; Francisco Albornoz; Jane P Griffin; David L Crandall; Hassan Elokdah; Agnes B Fogo; Douglas E Vaughan; Nancy J Brown
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-12-02       Impact factor: 8.311

8.  Plasminogen Activator Inhibitor-1 Promotes Neutrophil Infiltration and Tissue Injury on Ischemia-Reperfusion.

Authors:  Marc Praetner; Gabriele Zuchtriegel; Martin Holzer; Bernd Uhl; Johanna Schaubächer; Laura Mittmann; Matthias Fabritius; Robert Fürst; Stefan Zahler; Dominik Funken; Maximilian Lerchenberger; Andrej Khandoga; Sandip Kanse; Kirsten Lauber; Fritz Krombach; Christoph A Reichel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-25       Impact factor: 8.311

9.  Angiotensin II type 1 receptors and the intestinal microvascular dysfunction induced by ischemia and reperfusion.

Authors:  Thomas Petnehazy; Dianne Cooper; Karen Y Stokes; Janice Russell; Katherine C Wood; D Neil Granger
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-02-09       Impact factor: 4.052

Review 10.  Current Mechanistic Concepts in Ischemia and Reperfusion Injury.

Authors:  Meng-Yu Wu; Giou-Teng Yiang; Wan-Ting Liao; Andy Po-Yi Tsai; Yeung-Leung Cheng; Pei-Wen Cheng; Chia-Ying Li; Chia-Jung Li
Journal:  Cell Physiol Biochem       Date:  2018-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.